Boehringer Ingelheim Venture Fund
Committed to advancing scientific innovation by investing in first-in-class, disease-modifying therapeutics across various modalities globally.
Ingelheim am Rhein, Germany · 40+ investments · 58 portfolio companies
- Headquarters
- Ingelheim am Rhein, Germany
- Founded
- 2010
- AUM
- $350.0M
- Portfolio Companies
- 58
- Total Investments
- 40
- Last Investment
- Apr 2026
- Geographic Focus
- China, Germany, United States
Investment Thesis
Boehringer Ingelheim Venture Fund is a Corporate VC firm based in Ingelheim am Rhein, Germany. It has made 40 investments, including T3 Pharmaceuticals, Rigontec and Click Therapeutics. Focus areas include Biotech and Digital Health.
Portfolio58
Co-investors24
Sign up to view co-investors
24 co-investors across 58 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×20 · Private Equity ×3 · Corporate VC ×1 · 63 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/boehringer-ingelheim-venture-fund"><img src="https://indexed.vc/api/badge/investor/boehringer-ingelheim-venture-fund" alt="Boehringer Ingelheim Venture Fund on Indexed.vc" width="260" height="76" /></a>